453 research outputs found
Paving the Way: The Influence of Early Research and Development Programs on Apollo, Saturn, and Legacy System Development
As we celebrate the 50th anniversary of the first successful human landings on the surface of the Moon in 1969, it is insightful to review the many historic accomplishments that contributed to this astounding human achievement. While the Apollo Program officially began following the charge by United States President John F. Kennedy in 1961, much of the foundation for Apollo was already underway with early research and development that began as early as the close of the second World War. Innovations and key decisions prior to the formal initiation of the Apollo Program, and even prior to the formation of the National Aeronautics and Space Administration (NASA), enabled the relatively rapid development of the Saturn V rocket, the Apollo capsule, and the Lunar Lander systems needed to achieve the goal of landing humans on the Moon and returning them safely to Earth by the close of the 1960s
In-space assembly-servicing requirements
A method for developing the requirements for in-space assembly, servicing, and checkout of the proposed Mars space transfer vehicles is discussed. Required in-space operations and functions are identified in relation to various Earth to Orbit (ETO) vehicles by looking at the manifesting options of baseline Mars Space Transfer Vehicles (STV). Each operation is then reduced to a minimum complexity state resulting in a set of operational primitive functions. These primitive functions are used to assess the tradeoffs between robotic, telerobotic, and EVA operations. The study demonstrates that the complexity of the in-space operations remains stable with ETO vehicle size, and therefore the functions, and ultimately the infrastructure required to support proposed missions, are relatively unaffected by varying the ETO vehicle size within the range considered for this study
Ares V: Shifting the Payload Design Paradigm
NASA is designing the Ares V heavy-lift cargo launch vehicle to send more crew and cargo to more places on the lunar surface than the 1960s-era Saturn V and to provide ongoing support for a permanent lunar outpost. This uncrewed cargo vehicle is designed to operate together with the Ares I crew vehicle (Figure 1). In addition to this role, however, its unmatched mass and volume capability represent a national asset for exploration, science, and commerce. The Ares V also enables or significantly enhances a large class of space missions not thought possible by scientists and engineers since the Saturn V program ended over 30 years ago. Compared to current systems, it will offer approximately five times the mass and volume to most orbits and locations. This should allow prospective mission planners to build robust payloads with margins that are three to five times the industry norm. The space inside the planned payload shroud has enough usable volume to launch the volumetric equivalent of approximately 10 Apollo Lunar Modules or approximately five equivalent Hubble Space Telescopes. This mass and volume capability to low-Earth orbit (LEO) enables a host of new scientific and observation platforms, such as telescopes, satellites, planetary and solar missions, as well as being able to provide the lift for future large in-space infrastructure missions, such as space based solar power and mining, Earth asteroid defense, propellant depots, etc. In addition, payload designers may also have the option of simplifying their designs or employing Ares V s payload as dumb mass to reduce technical and operational risk. The Ares V team is engaging the potential payload community now, two to three years before System Requirements Review (SRR), in order to better understand the additional requirements from the payload community that could be accommodated in the Ares V design in its conceptual phase. This paper will discuss the Ares V reference mission and capability, as well as its potential to perform other missions in the future
Aerodynamic Characteristics of Two Waverider-Derived Hypersonic Cruise Configurations
An evaluation was made on the effects of integrating the required aircraft components with hypersonic high-lift configurations known as waveriders to create hypersonic cruise vehicles. Previous studies suggest that waveriders offer advantages in aerodynamic performance and propulsion/airframe integration (PAI) characteristics over conventional non-waverider hypersonic shapes. A wind-tunnel model was developed that integrates vehicle components, including canopies, engine components, and control surfaces, with two pure waverider shapes, both conical-flow-derived waveriders for a design Mach number of 4.0. Experimental data and limited computational fluid dynamics (CFD) solutions were obtained over a Mach number range of 1.6 to 4.63. The experimental data show the component build-up effects and the aerodynamic characteristics of the fully integrated configurations, including control surface effectiveness. The aerodynamic performance of the fully integrated configurations is not comparable to that of the pure waverider shapes, but is comparable to previously tested hypersonic models. Both configurations exhibit good lateral-directional stability characteristics
NASA Centers and Universities Collaborate in Annual Smallsat Technology Partnerships
The Small Spacecraft Technology program within the NASA Space Technology Mission Directorate sponsors the Smallsat Technology Partnerships (STP) initiative. The STP initiative awards cooperative agreements between NASA centers and university teams for technology development efforts that advance the capabilities of small spacecraft to achieve NASA mission objectives in unique and more affordable ways.
NASA’s announcement to return humans to the Moon by 2024 raises new opportunities for Smallsats to contribute to missions in cislunar space, though technical challenges are to be overcome to establish their value in this environment. Precursor missions utilizing small spacecraft will blaze the trail for lunar exploration, establishing infrastructure such as communication and navigation networks, and performing assembly and repair services for larger structures and human habitats. To achieve these goals, certain novel Smallsat technologies will need to be developed and demonstrated. The 2020 STP solicitation sought proposals for specific technologies to enable these lunar missions.
For the 2020 STP cycle, NASA selected nine university teams to mature new systems and capabilities in the laboratory, and in some cases, demonstrate in suborbital or orbital spaceflights. This paper describes the STP portfolio, past and present efforts, and the nine partnerships selected
Induction of apoptosis in rat peripheral blood lymphocytes by the anticancer drug CI-994 (acetyldinaline)
ABSTRACT: CI-994 (acetyldinaline) is an investigational anticancer drug currently in clinical trials. In preclinical safety studies in rats and dogs, CI-994 resulted in significant toxicity to bone marrow and lymphoid tissue. To determine if apoptosis was involved in CI-994 toxicity, peripheral blood lymphocytes were isolated from untreated male Wistar rats and exposed to CI-994 (1, 3, 10, or 30 μM) in vitro for up to 24 hours. Morphological and biochemical features of apoptosis were evaluated using several techniques, and lactate dehydrogenase (LDH) release was measured as an indicator of cell necrosis. No evidence of apoptosis or necrosis was detected in lymphocytes exposed to CI-994 for 4 hours. After 24 hours, concentration-dependent increases in apoptosis characterized by DNA condensation, DNA fragmentation, and/or externalization of phosphatidyl serine were seen at CI-994 concentrations as low as 1 μM and were statistically significant beginning at 10 μM. Ultrastructural analysis confirmed the presence of DNA condensation, DNA fragmentation, cell shrinkage, and membrane blebbing in cells exposed to 30 μM CI-994. After 24 hours, the percent of maximum LDH release from lymphocytes treated with 10 and 30 μM CI-994 was 7% and 15%, respectively, compared with 0% in the controls. In comparison, morphological changes of apoptosis detected by fluorescent microscopy were observed in 79% of the lymphocytes at these two concentrations. Additionally, apoptosis was seen in more than 24% of lymphocytes exposed to 1 and 3 μM CI-994, whereas maximum LDH release was less than or equal to 1% at these concentrations. These results show that apoptosis is the primary mode of cell death in rat lymphocytes exposed to CI-994 in vitro
NASA Research Center Contributions to Space Shuttle Return to Flight (SSRTF)
Contributions provided by the NASA Research Centers to key Space Shuttle return-to-flight milestones, with an emphasis on debris and Thermal Protection System (TPS) damage characterization, are described herein. Several CAIB recommendations and Space Shuttle Program directives deal with the mitigation of external tank foam insulation as a debris source, including material characterization as well as potential design changes, and an understanding of Orbiter TPS material characteristics, damage scenarios, and repair options. Ames, Glenn, and Langley Research Centers have performed analytic studies, conducted experimental testing, and developed new technologies, analysis tools, and hardware to contribute to each of these recommendations. For the External Tank (ET), these include studies of spray-on foam insulation (SOFI), investigations of potential design changes, and applications of advanced non-destructive evaluation (NDE) technologies to understand ET TPS shedding during liftoff and ascent. The end-to-end debris assessment included transport analysis to determine the probabilities of impact for various debris sources. For the Orbiter, methods were developed, and validated through experimental testing, to determine thresholds for potential damage of Orbiter TPS components. Analysis tools were developed and validated for on-orbit TPS damage assessments, especially in the area of aerothermal environments. Advanced NDE technologies were also applied to the Orbiter TPS components, including sensor technologies to detect wing leading edge impacts during liftoff and ascent. Work is continuing to develop certified TPS repair options and to develop improved methodologies for reinforced carbon-carbon (RCC) damage progression to assist in on-orbit repair decision philosophy
NASA Crew Launch Vehicle Flight Test Options
Options for development flight testing (DFT) of the Ares I Crew Launch Vehicle (CLV) are discussed. The Ares-I Crew Launch Vehicle (CLV) is being developed by the U.S. National Aeronautics and Space Administration (NASA) to launch the Crew Exploration Vehicle (CEV) into low Earth Orbit (LEO). The Ares-I implements one of the components of the Vision for Space Exploration (VSE), providing crew and cargo access to the International Space Station (ISS) after retirement of the Space Shuttle and, eventually, forming part of the launch capability needed for lunar exploration. The role of development flight testing is to demonstrate key sub-systems, address key technical risks, and provide flight data to validate engineering models in representative flight environments. This is distinguished from certification flight testing, which is designed to formally validate system functionality and achieve flight readiness. Lessons learned from Saturn V, Space Shuttle, and other flight programs are examined along with key Ares-I technical risks in order to provide insight into possible development flight test strategies. A strategy for the first test flight of the Ares I, known as Ares I-1, is presented
Palmitate and insulin synergistically induce IL-6 expression in human monocytes
<p>Abstract</p> <p>Background</p> <p>Insulin resistance is associated with a proinflammatory state that promotes the development of complications such as type 2 diabetes mellitus (T2DM) and atherosclerosis. The metabolic stimuli that initiate and propagate proinflammatory cytokine production and the cellular origin of proinflammatory cytokines in insulin resistance have not been fully elucidated. Circulating proinflammatory monocytes show signs of enhanced inflammation in obese, insulin resistant subjects and are thus a potential source of proinflammatory cytokine production. The specific, circulating metabolic factors that might stimulate monocyte inflammation in insulin resistant subjects are poorly characterized. We have examined whether saturated nonesterified fatty acids (NEFA) and insulin, which increase in concentration with developing insulin resistance, can trigger the production of interleukin (IL)-6 and tumor necrosis factor (TNF)-α in human monocytes.</p> <p>Methods</p> <p>Messenger RNA and protein levels of the proinflammatory cytokines IL-6 and TNF-α were measured by quantitative real-time PCR (qRT-PCR) and Luminex bioassays. Student's <it>t</it>-test was used with a significance level of <it>p </it>< 0.05 to determine significance between treatment groups.</p> <p>Results</p> <p>Esterification of palmitate with coenzyme A (CoA) was necessary, while β-oxidation and ceramide biosynthesis were not required, for the induction of IL-6 and TNF-α in THP-1 monocytes. Monocytes incubated with insulin and palmitate together produced more IL-6 mRNA and protein, and more TNF-α protein, compared to monocytes incubated with palmitate alone. Incubation of monocytes with insulin alone did not affect the production of IL-6 or TNF-α. Both PI3K-Akt and MEK/ERK signalling pathways are important for cytokine induction by palmitate. MEK/ERK signalling is necessary for synergistic induction of IL-6 by palmitate and insulin.</p> <p>Conclusions</p> <p>High levels of saturated NEFA, such as palmitate, when combined with hyperinsulinemia, may activate human monocytes to produce proinflammatory cytokines and support the development and propagation of the subacute, chronic inflammatory state that is characteristic of insulin resistance. Results with inhibitors of β-oxidation and ceramide biosynthesis pathways suggest that increased fatty acid flux through the glycerolipid biosynthesis pathway may be involved in promoting proinflammatory cytokine production in monocytes.</p
Synergistic Development, Test, and Qualification Approaches for the Ares I and V Launch Vehicles
The U.S. National Aeronautics and Space Administration (NASA) initiated plans to develop the Ares I and Ares V launch vehicles in 2005 to meet the mission objectives for future human exploration of space. Ares I is designed to provide the capability to deliver the Orion crew exploration vehicle (CEV) to low-Earth orbit (LEO), either for docking to the International Space Station (ISS) or docking with an Earth departure stage (EDS) and lunar lander for transit to the Moon. Ares V provides the heavy-lift capability to deliver the EDS and lunar lander to orbit. An integrated test plan was developed for Ares I that includes un-crewed flight validation testing and ground testing to qualify structural components and propulsion systems prior to operational deployment. The overall test program also includes a single development test flight conducted prior to the Ares I critical design review (CDR). Since the Ares V concept was formulated to maximize hardware commonality between the Ares V and Ares I launch vehicles, initial test planning for Ares V has considered the extensibility of test approaches and facilities from Ares I. The Ares V test plan was part of a successful mission concept review (MCR) in 2008
- …